• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D filed by R1 RCM Inc.

    6/14/24 4:18:48 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary
    Get the next $RCM alert in real time by email
    SC 13D 1 d819182dsc13d.htm SC 13D SC 13D

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. )*

     

     

    R1 RCM Inc.

    (Name of Issuer)

    Common stock, par value $0.01 per share

    (Title of Class of Securities)

    77634L 105

    (CUSIP Number)

    Jeremy Delinsky

    433 W. Ascension Way, Suite 200,

    Murray, Utah 84123

    (312) 324-7820

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    June 12, 2024

    (Date of Event Which Requires Filing of This Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 77634L 105    Schedule 13D    Page 2 of 5

     

     (1)    

     Names of reporting persons

     

     Jeremy Delinsky

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     (3)  

     SEC use only

     

     (4)  

     Source of funds (see instructions)

     

     OO

     (5)  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     (6)  

     Citizenship or place or organization

     

     United States

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with:

     

        (7)    

     Sole voting power

     

     11,324

        (8)  

     Shared voting power

     

     0

        (9)  

     Sole dispositive power

     

     11,324

       (10)  

     Shared dispositive power

     

     0

    (11)    

     Aggregate amount beneficially owned by each reporting person

     

     11,324

    (12)  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    (13)  

     Percent of class represented by amount in Row (11)

     

     0.0%*

    (14)  

     Type of reporting person (see instructions)

     

     IN

     

    *

    Based on 421,255,230 shares of common stock, par value $0.01 per share (the “Common Stock”), of R1 RCM Inc. (the “Issuer”) outstanding as of May 6, 2024, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 8, 2024 (the “Form 10-Q”).


    CUSIP No. 77634L 105    Schedule 13D    Page 3 of 5

     

    Item 1. Securities and Issuer.

    This Schedule 13D (this “Statement”) relates to the Common Stock, of the Issuer. The address of the principal executive offices of the Issuer is 433 W. Ascension Way, Suite 200, Murray, Utah 84123.

    Item 2. Identity and Background

    (a) – (c), (f)

    This Statement is filed by Jeremy Delinsky (the “Reporting Person”).

    The Reporting Person has been a director of the Issuer since 2022. The Reporting Person has served in various executive roles in the past but does not currently have a primary occupation or employment. The business address for the Reporting Person and the Issuer is 433 W. Ascension Way, Suite 200, Murray, Utah 84123. The Reporting Person is a citizen of the United States.

    (d) – (e)

    During the last five years the Reporting Person has not: (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

    Item 3. Source and Amount of Funds or Other Consideration

    The information set forth in Item 4 of this Statement is incorporated herein by reference in its entirety.

    Item 4. Purpose of Transaction.

    On May 6, 2024, the Issuer granted a waiver of certain restrictions in that certain Investor Rights Agreement, dated as of June 21, 2022, by and among CoyCo 1, L.P. (“Coyco 1”), CoyCo 2, L.P. (“Coyco 2”) and the Issuer, in order to permit TCP-ASC ACHII Series LLLP, CoyCo 1, CoyCo 2 or their respective affiliates (collectively, the “Investor Parties”) to form, join and participate in a “group” (within the meaning of Section 13(d)(3) of the Exchange Act) with respect to the Common Stock of the Issuer for purposes of a transaction as a result of which the Investor Parties would jointly acquire all of the outstanding shares of the Common Stock of the Issuer not owned by the Investor Parties (a “Potential Transaction”) and (ii) granted certain approvals for purposes of antitakeover statutes, including Section 203 of the Delaware General Corporation Law (the “May 6 Waiver”).

    As permitted by the May 6 Waiver, the Investor Parties have been engaged in discussions throughout the past several weeks with respect to a Potential Transaction. In connection with these discussions, the Reporting Person, has and intends to continue to assist New Mountain Capital, L.L.C. (“New Mountain”) in conducting due diligence on the Issuer. The Reporting Person and New Mountain have had preliminary discussions and intend to continue to have discussions regarding the possibility of the Reporting Person serving in an executive capacity and/or advisory role with the Issuer following such Potential Transaction.

    The Reporting Person is or expects to be engaged in ongoing discussions with New Mountain. The Reporting Person has not reached any agreement, arrangement or understanding with any other person (including New Mountain) regarding any Potential Transaction. The Reporting Person disclaims the formation of any “group” (within the meaning of Section 13(d)(3) of the Act) with New Mountain at this time and also expressly disclaims the beneficial ownership of any shares of Common Stock held by New Mountain. The Reporting Person does not intend to update disclosures in this Statement regarding a Potential Transaction unless and until a definitive agreement has been reached, or unless disclosure is otherwise required under applicable U.S. securities laws.

    Except as described above, the Reporting Person has no plans or proposals which relate to or would result in any of the actions specified in paragraphs (a) through (j) of Item 4 of Schedule 13D. The Reporting Person may, at any time and from time to time, formulate other purposes, plans or proposals regarding the Issuer, or any other actions that could involve one or more of the types of transactions or have one or more of the results described in paragraphs (a) through (j) of Item 4 of Schedule 13D.


    CUSIP No. 77634L 105    Schedule 13D    Page 4 of 5

     

    Item 5. Interest in Securities of the Issuer.

    The information contained in rows 7, 8, 9, 10, 11 and 13 on the cover page of this Statement and the information set forth or incorporated in Items 2, 3, 4 and 6 is incorporated by reference in its entirety into this Item 5.

    (a) and (b) The percentages in this Item 5 and in other provisions of this Statement relating to beneficial ownership of Common Stock are based on based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.

    (c) During the past 60 days the Reporting Person has effected the following transactions in the Common Stock: On May 18, 2024, the Reporting Person acquired 11,324 shares of Common Stock upon the vesting of 11,324 restricted stock units granted to the Reporting Person by the Issuer in consideration for his service as a director of the Issuer. On May 23, 2024, the Reporting Person received a grant of 15,651 restricted stock units by the Issuer, as reported on the Form 4 filed May 23, 2024.

    (d) No other person is known to the Reporting Person to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock covered by this Statement.

    (e) Not applicable.

    Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to the Securities of the Issuer.

    The information set forth in Item 4 of this Statement is incorporated herein by reference in its entirety.

    To the best knowledge of the Reporting Person, except as provided herein, there are no other contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Persons and any other person with respect to any securities of the Issuer, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, divisions of profits or loss, or the giving or withholding of proxies, or a pledge or contingency, the occurrence of which would give another person voting power over the securities of the Issuer.

    Item 7. Materials to be Filed as Exhibits.

    None.


    CUSIP No. 77634L 105    Schedule 13D    Page 5 of 5

     

    Signatures

    After reasonable inquiry and to the best knowledge and belief of the undersigned, such person certifies that the information set forth in this Statement with respect to such person is true, complete and correct.

    Dated: June 13, 2024

     

    Jeremy Delinsky
        

    /s/ Jeremy Delinsky

    Get the next $RCM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RCM

    DatePrice TargetRatingAnalyst
    8/8/2024Overweight → Equal-Weight
    Morgan Stanley
    8/1/2024Overweight → Equal-Weight
    Stephens
    8/1/2024Outperform → Market Perform
    Leerink Partners
    8/1/2024Buy → Hold
    Jefferies
    4/10/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    3/20/2024$16.00Neutral → Buy
    Citigroup
    2/26/2024$14.00Outperform
    Leerink Partners
    1/3/2024$14.00Overweight
    Barclays
    More analyst ratings

    $RCM
    SEC Filings

    See more
    • SEC Form POSASR filed by R1 RCM Inc.

      POSASR - R1 RCM Inc. /DE (0001910851) (Filer)

      11/19/24 4:26:18 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form S-8 POS filed by R1 RCM Inc.

      S-8 POS - R1 RCM Inc. /DE (0001910851) (Filer)

      11/19/24 4:18:28 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form S-8 POS filed by R1 RCM Inc.

      S-8 POS - R1 RCM Inc. /DE (0001910851) (Filer)

      11/19/24 4:17:27 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director New Mountain Capital, L.L.C. disposed of $1,944,593,908 worth of shares (135,985,588 units at $14.30) (SEC Form 4)

      4 - R1 RCM Inc. /DE (0001910851) (Issuer)

      11/22/24 4:05:14 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Director Dill David M returned $708,165 worth of shares to the company (49,522 units at $14.30), closing all direct ownership in the company (SEC Form 4)

      4 - R1 RCM Inc. /DE (0001910851) (Issuer)

      11/19/24 5:37:21 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Director Henneman John B Iii returned $1,255,040 worth of shares to the company (87,765 units at $14.30), closing all direct ownership in the company (SEC Form 4)

      4 - R1 RCM Inc. /DE (0001910851) (Issuer)

      11/19/24 5:35:59 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Financials

    Live finance-specific insights

    See more
    • R1 RCM Reports Third Quarter 2024 Results

      MURRAY, Utah, Nov. 05, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2024. Third Quarter 2024 Results: Revenue of $656.8 million, up $84.0 million or 14.7% compared to the same period last year.GAAP net loss of $19.9 million, compared to net income of $1.3 million in the same period last year.Adjusted EBITDA of $148.2 million, compared to adjusted EBITDA of $161.5 million in the same period last year. The quarter reflects impacts to both revenue and costs as

      11/5/24 7:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM Reports Second Quarter 2024 Results

      MURRAY, Utah, Aug. 07, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2024. Second Quarter 2024 Results: Revenue of $627.9 million, up $67.2 million or 12.0% compared to the same period last year.GAAP net loss of $7.6 million, compared to net loss of $1.0 million in the same period last year.Adjusted EBITDA of $156.1 million, compared to adjusted EBITDA of $142.9 million in the same period last year. The quarte

      8/7/24 7:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM to be Acquired by TowerBrook and CD&R for $8.9 Billion

      MURRAY, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice ("CD&R"), in an all-cash transaction with an enterprise value of approximately $8.9 billion. An investment vehicle controlled by TowerBrook is currently the beneficial owner of approximately 36% of the Company's outstanding shares of common stock, including the warrant held by TowerBrook.

      8/1/24 7:30:34 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Leadership Updates

    Live Leadership Updates

    See more
    • Shift4 Payments Set to Join the S&P MidCap 400

      NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Shift4 Payments Inc. (NYSE:FOUR) will replace R1 RCM Inc. (NASD:RCM) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 20. TowerBrook Capital Partners and Clayton, Dublier & Rice will acquire R1 RCM in a transaction expected to be completed on or about November 19. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector November 20, 2024 S&P MidCap 400 Addition Shift4 Payments FOUR Financials S&P MidCap 400 Deletion R1 RCM RCM Health Care For more information about S&P Dow Jones Indices, ple

      11/15/24 6:15:00 PM ET
      $FOUR
      $RCM
      $SPGI
      Business Services
      Consumer Discretionary
      Other Consumer Services
      Finance: Consumer Services
    • James Hardie Industries Announces Global Leadership Appointment

      Rachel Wilson appointed as Chief Financial Officer (CFO) James Hardie Industries plc ((ASX: JHX, NYSE:JHX), the world's #1 producer and marketer of high-performance fiber cement and fiber gypsum building solutions, today announced the appointment of Ms. Rachel Wilson as Chief Financial Officer, effective immediately. As a member of the global executive team, Ms. Wilson will report directly to Chief Executive Officer Aaron Erter. Ms. Wilson was appointed after Jason Miele stepped down as Chief Financial Officer. Mr. Miele will remain with the Company for three months as an advisor to the Chief Executive Officer for special projects and will thereafter depart the organization. "I would li

      8/16/23 9:50:00 PM ET
      $JHX
      $RCM
      Building Materials
      Industrials
      Other Consumer Services
      Consumer Discretionary
    • R1 Announces Appointment of Agnes Bundy Scanlan to Board of Directors

      MURRAY, Utah, Aug. 12, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the appointment of Agnes Bundy Scanlan, president of The Cambridge Group LLC, to the company's board of directors, effective August 11, 2021. Ms. Bundy Scanlan has more than 30 years of experience across regulatory risk management, compliance, and consumer financial protection. She has served as president of The Cambridge Group LLC, a regulatory risk management advisory firm, since May 2020. Prior to this role, Ms. Bundy Scanlan served as senior advisor at Trelian

      8/12/21 8:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $RCM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • R1 RCM downgraded by Morgan Stanley

      Morgan Stanley downgraded R1 RCM from Overweight to Equal-Weight

      8/8/24 8:58:18 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM downgraded by Stephens

      Stephens downgraded R1 RCM from Overweight to Equal-Weight

      8/1/24 9:39:53 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM downgraded by Leerink Partners

      Leerink Partners downgraded R1 RCM from Outperform to Market Perform

      8/1/24 9:39:53 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • TowerBrook and CD&R Complete Acquisition of R1 RCM

      MURRAY, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. ("R1"), a leader in automating revenue management for healthcare providers, today announced that investment funds affiliated with TowerBrook Capital Partners ("TowerBrook") and Clayton, Dubilier & Rice ("CD&R") have completed their previously announced acquisition of R1. On August 1, 2024, TowerBrook, CD&R and R1 announced that they had entered into a definitive merger agreement under which all outstanding shares of R1 common stock that TowerBrook did not own would be acquired for $14.30 per share in cash, valuing R1 at approximately $8.9 billion. With the completion of the transaction, R1's common stock has ceased trading and w

      11/19/24 9:06:28 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Shift4 Payments Set to Join the S&P MidCap 400

      NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Shift4 Payments Inc. (NYSE:FOUR) will replace R1 RCM Inc. (NASD:RCM) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 20. TowerBrook Capital Partners and Clayton, Dublier & Rice will acquire R1 RCM in a transaction expected to be completed on or about November 19. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector November 20, 2024 S&P MidCap 400 Addition Shift4 Payments FOUR Financials S&P MidCap 400 Deletion R1 RCM RCM Health Care For more information about S&P Dow Jones Indices, ple

      11/15/24 6:15:00 PM ET
      $FOUR
      $RCM
      $SPGI
      Business Services
      Consumer Discretionary
      Other Consumer Services
      Finance: Consumer Services
    • R1 RCM Reports Third Quarter 2024 Results

      MURRAY, Utah, Nov. 05, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2024. Third Quarter 2024 Results: Revenue of $656.8 million, up $84.0 million or 14.7% compared to the same period last year.GAAP net loss of $19.9 million, compared to net income of $1.3 million in the same period last year.Adjusted EBITDA of $148.2 million, compared to adjusted EBITDA of $161.5 million in the same period last year. The quarter reflects impacts to both revenue and costs as

      11/5/24 7:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

      SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

      11/22/24 4:06:56 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

      SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

      11/19/24 4:36:38 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

      SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

      8/5/24 7:31:56 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary